The hottest Pharmaceutical Machinery Industry Mark

2022-08-13
  • Detail

Pharmaceutical Machinery Industry Market Research Report (I)

the pharmaceutical (machinery) equipment industry has been developing and expanding since 1978. In recent years, with the sustained and high-speed development of China's economic situation and the continuous improvement of people's living standards, people's demand for medical health is higher and higher, and the demand for the quality and quantity of drugs is significantly improved. Therefore, it has driven the rapid development of the pharmaceutical industry, promoted the growth of the demand for pharmaceutical machinery, and promoted the prosperity of the pharmaceutical equipment industry

I. overview of the pharmaceutical machinery market

at present, there are more than 800 pharmaceutical machinery enterprises specializing in and concurrently producing (mainly pharmaceutical machinery products) in China, which are distributed in 26 provinces, municipalities and autonomous regions across the country. The apparent demand of special equipment manufacturing market in China's pharmaceutical industry in 2002 was 5.1 billion yuan, an increase of 30.1% over 3.92 billion yuan in 2001, showing the rapid development trend of pharmaceutical machinery industry in recent years

the products of pharmaceutical machinery industry are divided into eight categories, including API machinery and equipment, preparation machinery, pharmaceutical crushing machinery, decoction pieces machinery, pharmaceutical water equipment, pharmaceutical packaging machinery, pharmaceutical testing equipment and other pharmaceutical machinery and equipment. In this wide range of products, there are not only advanced single machine equipment, but also a complete set of automatic production units, more than 3000 varieties and specifications of pharmaceutical machine products. It has not only provided a large number of high-quality advanced equipment for the capital construction, technological transformation and equipment upgrading of more than 6000 Chinese and Western pharmaceutical factories and thousands of health care products enterprises in China, but also exported to dozens of countries and regions such as the United States, Japan, South Korea, Russia, Thailand, Indonesia, Malaysia, the Philippines, Pakistan, Hong Kong and so on. In recent years, there has been a huge trade deficit in the import and export of pharmaceutical machinery products. In 2002, the export volume of pharmaceutical machinery was 17.95 million US dollars, and the import volume was 185.9 million US dollars, accounting for only 8.8% of the total import and export volume

in recent years, new products in the pharmaceutical machinery industry have increased day by day, and the quality has also made a great leap. Some products have reached the international advanced level. In 2003, the product sales revenue of 50 major enterprises in China's pharmaceutical machinery manufacturing industry was about 18 500 million yuan, with a profit of about 135 million yuan. There are three main reasons for the popularity of the pharmaceutical machinery industry:

first, the sustained and rapid development of China's economic situation and the continuous improvement of people's living standards have led to the rapid development of the pharmaceutical industry, which has promoted the demand growth of pharmaceutical machinery and the prosperity of the pharmaceutical equipment industry

second, the promotion of the compulsory GMP certification system for pharmaceutical enterprises by the state requires high temperature resistance, especially the deadline for GMP certification, which is a direct factor for the booming pharmaceutical machine market. The production range of alloy structural steel with high added value for pharmaceutical equipment is an important part of GMP hardware. Since the country launched the GMP compulsory certification system, local pharmaceutical companies have accelerated the pace of technological transformation, and the substantial renewal of production equipment has brought significant benefits to the upstream industry of the pharmaceutical industry - the pharmaceutical machinery industry. A large number of production line transformations have brought huge markets to pharmaceutical machinery enterprises

the third is the promotion of scientific and technological progress in the pharmaceutical machinery industry. In recent years, China's pharmaceutical machinery industry has paid close attention to scientific and technological progress, with an increasing number of new products and a great leap in quality. Some products have even reached the international advanced level

although China's pharmaceutical equipment industry has developed rapidly in recent years, it has promoted the large-scale and modern development of pharmaceutical production technology. However, the development level of China's pharmaceutical equipment technology is basically limited to the imitation, improvement and combination stages, which does not reach the level of innovation or exceed the level of similar products in the world. At present, the development level of China's pharmaceutical equipment is 10 to 20 years worse than that of foreign pharmaceutical equipment. The main reasons for the slow development of China's pharmaceutical equipment technology are as follows:

1 There is a great shortage of compound talents in pharmaceutical equipment in China, and the professional teaching level is low. Pharmaceutical equipment is a special specialty, integrating pharmaceutical technology, chemical machinery, refrigeration, automatic control, packaging machinery, manufacturing technology, welding, automatic control, computer application and other majors. The idea of pharmaceutical equipment R & D is to put these related majors through the whole design confirmation process. At present, few people engaged in pharmaceutical equipment R & D can skillfully take into account two or three majors, and a single professional is difficult to inject these professional elements into the R & D concept. At present, although the number of pharmaceutical equipment majors in Colleges and universities has increased, the professional teaching level is not satisfactory, there is no basic teaching materials, and the theoretical and practical application level of teaching staff is not skilled enough

2. The competitive price reduction of pharmaceutical equipment has stepped into the misunderstanding of hindering development

at present, China's pharmaceutical equipment has stepped into the misunderstanding of competitive price reduction sales. There are zero down payment, payment after use, sales below the cost price, etc., which will inevitably lead to Jerry built, low-grade configuration, high price spare parts in the future, unable to ensure the quality of the whole machine and poor after-sales service. In this way, the manufacturer is in a hurry to achieve success or clear the inventory, and the user does not trust the manufacturer. The manufacturer often rushes around for payment, making the enterprise's capital turnover abnormal and unable to invest enough funds in the research and development of new products. In addition, low price competition leads to low product quality, which will also affect the product quality of the user, and even cause medical accidents in serious cases

3. Pharmaceutical equipment can not really focus on the actual process of drug production

the basis of pharmaceutical equipment is to focus on the actual process of drug production. Some pharmaceutical equipment factories have not really understood the actual production process, and regardless of whether the requirements put forward by the pharmaceutical factory are correct or not, they blindly follow them. The equipment formed in this way has imperfections in detail, depth, connectivity, CIP and other requirements

4. Ignoring the automatic quality assurance inspection link of pharmaceutical equipment

and the control process equipment that is crucial to the quality of drug production, that is, the so-called automatic quality assurance inspection equipment (aqai), which can prevent any packaging errors (such as the size is better to cover the lower jaw, no instructions, single box is used incorrectly, insufficient weight and product confusion), it includes bar code system, video system, label omission detector Bottle overturning and purging device, automatic weighing and inspection device, etc. Nowadays, pharmaceutical equipment factories often ignore these links and think that the R & D cost of these links is too large. With the continuous promotion of GMP in China, people put forward higher requirements for drug quality. The improvement of process requires the renewal of equipment, and the new equipment will promote the improvement of process

5. Do not pay attention to small-scale trials and test links

pharmaceutical equipment has many necessary links related to small-scale trials and tests, such as traditional Chinese medicine extraction, "three in one", boiling drying, coating and other equipment, and its process parameter setting and changes directly affect the quality of finished products. At present, pharmaceutical equipment manufacturers are keen on development. Most of them do not set up small-scale test and test devices in their own factories, which can not achieve the situation that once the pharmaceutical factory provides samples, the pharmaceutical machine factory can immediately test the process parameters and make the finished products. Some often rely on the pharmaceutical factory using this product to complete this link

at the same time, our factory has small-scale tests and test devices, which can be used in many tests. 3. Install the experimental gearbox, find the defects of our products, find the way to upgrade, and also accumulate process parameters. Foreign peers attach great importance to this aspect. With the development of national GMP certification and follow-up work, these problems have gradually been paid attention to by government departments and enterprises, and gradually began to improve, laying a solid foundation for the all-round development of China's pharmaceutical industry. (1) (II) (III) (IV) (V) (VI) (VII)

Copyright © 2011 JIN SHI